Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework

por Greenwald, Mark K.
Publicado 2018

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder

por Heidbreder, Christian, Fudala, Paul J., Greenwald, Mark K.
Publicado 2023

A randomized, sham-controlled, quintuple-blinded trial to evaluate the NET device as an alternative to medication for promoting opioid abstinence

por Greenwald, Mark K., Ghosh, Samiran, Winston, Joe R.
Publicado 2022

Effects of neuromodulation on cognitive and emotional responses to psychosocial stressors in healthy humans

por Moses, Tabitha E.H., Gray, Elizabeth, Mischel, Nicholas, Greenwald, Mark K.
Publicado 2023

Training medical students in opioid overdose prevention and response: Comparison of In-Person versus online formats

por Moses, Tabitha E. H., Moreno, Jessica L., Greenwald, Mark K., Waineo, Eva
Publicado 2021

A Novel Online Curriculum and Coaching Strategy to Expand the Addiction Medicine Workforce: The Michigan Collaborative Addiction Resources and Education System

por Poland, Cara, Bennett, Lia, Strutz, Kelly L., Plantegenest, Geraud, Greenwald, Mark K.
Publicado 2022

Anhedonia modulates benzodiazepine and opioid demand among persons in treatment for opioid use disorder

por Greenwald, Mark K., Moses, Tabitha E. H., Lundahl, Leslie H., Roehrs, Timothy A.
Publicado 2023

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder

por Greenwald, Mark K., Wiest, Katharina L., Haight, Barbara R., Laffont, Celine M., Zhao, Yue
Publicado 2023

HIV chronicity as a predictor of hippocampal memory deficits in daily cannabis users living with HIV

por Woodcock, Eric A., Greenwald, Mark K., Chen, Irene, Feng, Danni, Cohn, Jonathan A., Lundahl, Leslie H.
Publicado 2023

Effects of cocaine and/or heroin use on resting cardiovascular function

por Greenwald, Mark K., Lundahl, Leslie H., Shkokani, Lina A., Syed, Shabber, Roxas, Renato S., Levy, Phillip D.
Publicado 2021

Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program

por Moses, Tabitha E, Rhodes, Gary L, Tavakoli, Emytis, Christensen, Carl W, Amirsadri, Alireza, Greenwald, Mark K
Publicado 2022

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder

por Laffont, Celine M., Ngaimisi, Eliford, Gopalakrishnan, Mathangi, Ivaturi, Vijay, Young, Malcolm, Greenwald, Mark K., Heidbreder, Christian
Publicado 2022

Evidence on Buprenorphine Dose Limits: A Review

por Grande, Lucinda A., Cundiff, Dave, Greenwald, Mark K., Murray, MaryAnne, Wright, Tricia E., Martin, Stephen A.
Publicado 2023

Parental Support, Mental Health, and Alcohol and Marijuana Use in National and High-Risk African-American Adolescent Samples

por Maslowsky, Julie, Schulenberg, John, Chiodo, Lisa M., Hannigan, John H., Greenwald, Mark K., Janisse, James, Sokol, Robert J., Delaney-Black, Virginia
Publicado 2016

Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes

por Trendowski, Matthew R., Lusk, Christine M., Ruterbusch, Julie J., Seaton, Randell, Simon, Michael S., Greenwald, Mark K., Harper, Felicity W. K., Beebe‐Dimmer, Jennifer L., Schwartz, Ann G.
Publicado 2021

Prevalence and predictors of peripheral neuropathy after breast cancer treatment

por Kamgar, Mandana, Greenwald, Mark K., Assad, Hadeel, Hastert, Theresa A., McLaughlin, Eric M., Reding, Kerryn W, Paskett, Electra D., Bea, Jennifer W., Shadyab, Aladdin H., Neuhouser, Marian L., Nassir, Rami, Crane, Tracy E., Sreeram, Kalyan, Simon, Michael S.
Publicado 2021